Elisa Petris

Elisa Petris

Lead Partner

Elisa is a Lead Partner of Syncona Investment Management Ltd.

She is a Director on the Board of Quell Therapeutics and was previously on the Board of former portfolio company Blue Earth Diagnostics. She was closely involved in the foundation of both Quell and Blue Earth, including their operational and strategic set-up.

Previously, she was a Senior Associate at Michel Dyens & Co. working on transactions covering the healthcare space, and a member of the Life Science team at L.E.K. Consulting based in London. While at L.E.K. she worked on projects for biotech, pharma and private equity clients. Elisa has a PhD in Molecular Biology from Imperial College and an MBA from London Business School.

Syncona portfolio companies

  • Neogene Therapeutics
  • Achilles Therapeutics
  • Quell Therapeutics (Board member)
Martin Murphy

Martin Murphy

Chief Executive Officer
Chris Hollowood

Chris Hollowood

Chief Investment Officer
Markus John

Markus John

Chief Medical Officer and Head of R&D
Edward Hodgkin

Edward Hodgkin

Senior Partner
Magdalena Jonikas

Magdalena Jonikas

Lead Partner
Alex Hamilton

Alex Hamilton

Investment Partner
Michael Kyriakides

Michael Kyriakides

Investment Partner
Gonzalo Garcia

Gonzalo Garcia

Investment Partner
Alice Renard

Alice Renard

Investment Partner
Raghd Rostom

Raghd Rostom

Associate Partner
Lisa Bright

Lisa Bright

Commercial Advisor
Ben Woolven

Ben Woolven

Business Strategy and Operations Partner